MediPharm Labs Corp. MEDIF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.34M | 7.41M | 8.29M | 8.10M | 7.80M |
| Total Receivables | 5.12M | 4.68M | 5.49M | 5.54M | 5.88M |
| Inventory | 6.81M | 6.00M | 5.73M | 5.69M | 6.69M |
| Prepaid Expenses | 442.90K | 98.90K | 245.80K | 384.80K | 538.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 314.10K | 238.60K | 279.30K | 330.20K | 728.80K |
| Total Current Assets | 20.03M | 18.43M | 20.03M | 20.05M | 21.64M |
|
|
|||||
| Total Current Assets | 20.03M | 18.43M | 20.03M | 20.05M | 21.64M |
| Net Property, Plant & Equipment | 11.95M | 12.36M | 12.83M | 12.88M | 13.56M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 412.60K | 452.10K | 492.30K | 516.90K | 560.20K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | 395.20K |
| Total Assets | 32.39M | 31.25M | 33.36M | 33.45M | 36.15M |
|
|
|||||
| Total Accounts Payable | 3.95M | 3.27M | 3.44M | 3.40M | 3.38M |
| Total Accrued Expenses | 2.31M | 2.06M | 2.72M | 1.65M | 2.08M |
| Short-term Debt | 289.40K | -- | 109.40K | 252.00K | 329.90K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.00K | 12.90K | 37.20K | 51.70K | 60.10K |
| Total Finance Division Other Current Liabilities | 882.30K | 763.70K | 933.50K | 922.50K | 1.10M |
| Total Other Current Liabilities | 882.30K | 763.70K | 933.50K | 922.50K | 1.10M |
| Total Current Liabilities | 7.44M | 6.10M | 7.24M | 6.27M | 6.95M |
|
|
|||||
| Total Current Liabilities | 7.44M | 6.10M | 7.24M | 6.27M | 6.95M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 289.40K | -- | 109.40K | 252.00K | 329.90K |
| Capital Leases | -- | -- | -- | -- | 7.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.44M | 6.10M | 7.24M | 6.27M | 6.96M |
|
|
|||||
| Common Stock & APIC | 142.29M | 144.64M | 147.25M | 144.76M | 147.84M |
| Retained Earnings | -119.88M | -121.97M | -123.53M | -135.42M | -136.74M |
| Treasury Stock & Other | 2.54M | 2.46M | 2.40M | 17.84M | 18.09M |
| Total Common Equity | 24.95M | 25.14M | 26.12M | 27.18M | 29.19M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 24.95M | 25.14M | 26.12M | 27.18M | 29.19M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 24.95M | 25.14M | 26.12M | 27.18M | 29.19M |
|
|
|||||